60
Participants
Start Date
December 8, 2025
Primary Completion Date
April 9, 2028
Study Completion Date
April 9, 2028
Antiandrogen Therapy
Given ADT
Behavioral Intervention
Receive fasting reminders via Oncpatient Companion Mobile Application
Biospecimen Collection
Undergo blood sample collection
Cardiac Computerized Tomographic Angiography
Undergo a coronary computerized tomography angiography
Computed Tomography
Undergo CT
Electronic Health Record Review
Ancillary studies
Internet-Based Intervention
Complete survey and food diary collection via Oncpatient Companion Mobile Application
Lifestyle Counseling
Receive diet and lifestyle counseling
Medical Device Usage and Evaluation
Wear an activity tracker
Nutritional Intervention
Receive AHA HHD guidelines
Nutritional Intervention
Receive AHA Life Essential 8 recommendations with personalized caloric intake
Questionnaire Administration
Ancillary studies
Radiation Therapy
Undergo RT
Referral
Receive a referral to an endocrinologist
Semaglutide
Given SC
Short-Term Fasting
Participate in an overnight fast
Tirzepatide
Given SC
RECRUITING
City of Hope Medical Center, Duarte
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER